A PHASE I CLINICAL TRIAL OF EPO906 IN COMBINATION WITH OXALIPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS

被引：0
|
作者：
Keefe, S. M. [1 ]
Avadhani, A. N. [1 ]
Flaherty, K. T. [1 ]
Redlinger, M. [1 ]
O'Dwyer, P. J. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] A phase I clinical and pharmacokinetic study of EPO906 (epothilone B) in patients with advanced solid tumours.
    Calvert, PM
    O'Neill, V
    Azzabi, A
    Hughes, A
    Plummer, R
    Twelves, C
    Robinson, A
    Machan, MA
    Dimitrijevic, S
    Moss, D
    Rothermel, J
    Cohen, P
    Chen, T
    Man, A
    Calvert, AH
    CLINICAL CANCER RESEARCH, 2000, 6 : 4581S - 4581S
  • [2] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Syma Iqbal
    Heinz-Josef Lenz
    David R. Gandara
    Stephen I. Shibata
    Susan Groshen
    Timothy W. Synold
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 85 - 91
  • [3] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Iqbal, Syma
    Lenz, Heinz-Josef
    Gandara, David R.
    Shibata, Stephen I.
    Groshen, Susan
    Synold, Timothy W.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 85 - 91
  • [4] Phase I trial of combination becatecarin and oxaliplatin in patients with advanced solid tumors
    Manda, S.
    Mauser, C.
    Bokar, J.
    Cooney, M.
    Brell, J.
    Krishnamurthi, S.
    Savvides, P.
    Ivy, P.
    Remick, S.
    Dowlati, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Preliminary results from a Phase II trial of EPO906 patients with advanced refractory ovarian cancer
    Kaye, S
    Oza, A
    Gore, M
    Huinink, W
    Smit, W
    Gibbon, D
    Miller, W
    Mull, R
    Chitale, K
    Rothermel, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S43 - S43
  • [6] Phase I dose-escalation trial investigating the safety and tolerability of EPO906 plus gemcitabine in patients with advanced cancer
    Rinehart, JJ
    Rothermel, JD
    Anderson, J
    Lorusso, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 219S - 219S
  • [7] UFT in combination with oxaliplatin:: clinical phase I study in patients with advanced or metastatic solid tumors
    Sastre, Javier
    Aranda, Enrique
    Abad, Albert
    Gallego, Javier
    Luis Manzano, Jose
    Gomez, Auxiliadora
    Carrato, Alfredo
    Lopez, Eva
    Diaz-Rubio, Eduardo
    ANTI-CANCER DRUGS, 2006, 17 (04) : 417 - 421
  • [8] Phase I clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumors.
    Alexandre, J
    Tchen, N
    Berthault-Cvitkovic, F
    Misset, JL
    Benettaib, B
    Kahatt, C
    Raymond, E
    Weems, G
    MacDonald, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9057S - 9057S
  • [9] Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors
    Ryan, David P.
    Appleman, Leonard J.
    Lynch, Thomas
    Supko, Jeffrey G.
    Fidias, Panagiotis
    Clark, Jeffrey W.
    Fishman, Mayer
    Zhu, Andrew X.
    Enzinger, Peter C.
    Kashala, Oscar
    Cusack, James, Jr.
    Eder, Joseph P.
    CANCER, 2006, 107 (10) : 2482 - 2489
  • [10] A clinical phase I trial of topotecan in combination with carboplatin in patients with advanced solid tumors
    Thodtmann, R
    Kemmerich, M
    Depenbrock, H
    Heuser, A
    van Oosterom, AT
    Hanauske, AR
    ANNALS OF ONCOLOGY, 1998, 9 : 69 - 69
12345